Implication of telomere length as a proliferation-associated marker in schwannomas

被引:2
|
作者
Chen, HJ
Cho, CL
Liang, CL
Lu, K
Lin, JW
机构
[1] Chang Gung Univ & Med Ctr, Dept Neurosurg, Kaohsiung, Taiwan
[2] Chang Gung Univ & Med Ctr, Dept Pathol, Kaohsiung, Taiwan
[3] Natl Sun Yat Sen Univ, Dept Biol, Kaohsiung 80424, Taiwan
关键词
telomere length; telomerase; schwannomas;
D O I
10.1002/jso.10139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Some schwannomas in the central nervous system may demonstrate relatively aggressive behavior in pathological findings and clinical course. We evaluate the diagnostic values of telomerase activity and telomere length in the clinicopathological behavior of schwannomas. Methods: Thirty surgical specimens from intracranial and intraspinal schwannomas were analyzed by polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) for telomerase activity and terminal restriction fragments (TRFs) using Southern blot for telomere length. Proliferative indices were also studied. Results: Telomerase activity could not be detected in all schwannomas. Elongated telomere length (mean 17,101 +/- 259 bp) was found in four specimens (13.3%). Three of these four were found to have mitotic figures, high vascularity, cellularity, and pleomorphism in the pathological findings. The proliferative indices (less than or equal to15) showed correlative high values. One patient died of this disease, and one was found to have recurrence at follow-up evaluation. Those that displayed benign histopathological pictures showed relatively short telomere length (8,866 +/- 271 base pairs) and low proliferative indices (less than or equal to1). These is a significant difference between these two groups (P = 0.001). Conclusions: Elongation of telomere length in schwannomas appears to predict aggressive clinicopathological behavior. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 50 条
  • [1] Implication of telomere length as a proliferation-associated marker in schwannomas - Commentary
    Broaddus, WC
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (02) : 100 - 100
  • [2] TELOMERE LENGTH AND ITS IMPLICATION AS PROGNOSTIC MARKER IN OVARIAN CANCER PATIENTS
    Atallah, D.
    Antoun, S.
    Moubarak, M.
    El Kassis, N.
    Tahtouh, R.
    Chahine, G.
    Hilal, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A434 - A434
  • [3] TELOMERE LENGTH AND ITS IMPLICATION AS PROGNOSTIC MARKER IN OVARIAN CANCER PATIENTS
    Atallah, D.
    Antoun, S.
    Moubarak, M.
    El Kassis, N.
    Tahtouh, R.
    Chahine, G.
    Hilal, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 631 - 631
  • [4] Radiation sensitivity increases with proliferation-associated telomere dysfunction in nontransformed human epithelial cells
    Soler, David
    Pampalona, Judit
    Tusell, Laura
    Genesca, Anna
    AGING CELL, 2009, 8 (04): : 414 - 425
  • [5] Telomere length and its implication as prognostic marker in ovarian cancer patients.
    Atallah, David M.
    Antoun, Stephanie
    Moubarak, Malak
    EL Kassis, Nadine
    Chahine, Georges Y.
    Hilal, George
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] PROLIFERATION-ASSOCIATED MARKERS IN THE CELIAC DUODENUM
    MCDEVITT, J
    OFARRELLY, C
    WEIR, DG
    OMARY, MB
    FEIGHERY, C
    KELLEHER, D
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (03) : 223 - 228
  • [7] PEROXISOME PROLIFERATION-ASSOCIATED POLYPEPTIDE IN LIVER
    KUMAR, NS
    REDDY, JK
    JOURNAL OF CELL BIOLOGY, 1977, 75 (02): : A196 - A196
  • [8] Utility of proliferation-associated marker MIB-1 in evaluating lesions of the uterine cervix
    Mittal, K
    ADVANCES IN ANATOMIC PATHOLOGY, 1999, 6 (04) : 177 - 185
  • [9] Telomere length: a marker for reproductive aging?
    Pirtea, Paul
    Keefe, David L.
    Ayoubi, Jean Marc
    de Ziegler, Dominique
    FERTILITY AND STERILITY, 2024, 121 (01) : 1 - 3
  • [10] Telomere length as a biological marker in malignancy
    Svenson, Ulrika
    Roos, Goran
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (04): : 317 - 323